pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health131
viewlistcards
  • Marketed
    Divalproex Sodium DR Viatris
    Divalproex Sodium
    Absence Seizure Mylan Pharmaceuticals Inc
  • Marketed
    Dobutamine Hydrochloride Pfizer
    Dobutamine Hydrochloride
    Congestive Heart Failure (Heart Failure)$PFE PFIZER INC
  • Marketed
    Dorlan
    Flurbiprofen
    Osteoarthritis Pain Teva Pharmaceuticals USA Inc
  • Marketed
← prev
page 88 of 271
next →
Pain89
Neurology1
Doryx
Doryx MPC (doxycycline hyclate)
Actinomycosis
Mayne Pharma USA Inc
  • Marketed
    Doxorubicin Teva
    Doxorubicin Hydrochloride (doxorubicin)
    Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leuk… Teva Pharmaceuticals USA Inc
  • Preclinical
    Drug for Anal Fissure
    Anal Fissure Steel Therapeutics Inc
  • Phase 1
    Drug for Unspecified Dermatological Disorders
    Unspecified Dermatological Disorders TBT Pharma Inc
  • Preclinical
    Drug to Inhibit MDM2 for Retinoblastoma
    Retinoblastoma Spectocular LLC
  • Preclinical
    Drugs for Oncology
    Pancreatic Ductal Adenocarcinoma SRI International
  • Marketed
    Duac
    Benzoyl Peroxide + Clindamycin Phosphate Prasco ((benzoyl peroxide + clindamycin phosphate))
    Acne Vulgaris Prasco LLC
  • Marketed
    Duraclon
    Duraclon (clonidine hydrochloride)
    Cancer Pain Mylan Pharmaceuticals Inc
  • Phase 1
    E-1018
    Malaria Eisai Co Ltd
  • Preclinical
    E-1V111
    Spinal Muscular Atrophy (SMA) Shift Pharmaceuticals
  • Phase 1
    E-2025
    Alzheimer's Disease Eisai Co Ltd
  • Phase 1
    E-2086
    Type 1 Narcolepsy (Narcolepsy with Cataplexy) Eisai Co Ltd
  • Phase 1
    E-2511
    Alzheimer's Disease Eisai Co Ltd
  • Phase 1
    E-7766
    Solid Tumor Eisai Co Ltd
  • Preclinical
    EB-002
    Anxiety Disorders MycoMedica Life Sciences PBC
  • Preclinical
    EB-003
    Hemolytic Uremic Syndrome Eligo Bioscience SA
  • Preclinical
    EB-07
    paridiprubart [INN]
    Pulmonary Fibrosis$EDSA Edesa Biotech, Inc.
  • Phase 2
    EB-103
    B-Cell Non-Hodgkin Lymphoma$ESLA Estrella Immunopharma, Inc.
  • Preclinical
    EB-104
    Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leuk…$ESLA Estrella Immunopharma, Inc.
  • Phase 1
    EB-105
    Diabetic Macular Edema Eluminex Biosciences Ltd
  • EBANGA
    EBANGA (ANSUVIMAB-ZYKL)
    no indication Ridgeback Biotherapeutics LLC
  • Phase 1
    EBC-129
    Pancreatic Ductal Adenocarcinoma Agency for Science, Technology and Research
  • EBGLYSS
    EBGLYSS (LEBRIKIZUMAB-LBKZ)
    1 INDICATIONS AND USAGE EBGLYSS is indicated for the trea…$LLY ELI LILLY & Co
  • Phase 2
    EBT-101
    Human Immunodeficiency Virus (HIV) Infections (AIDS) Excision BioTherapeutics Inc
  • Phase 2
    ECC-0509
    Metabolic Dysfunction-Associated Steatohepatitis (MASH or… Eccogene (Shanghai) Co Ltd
  • Phase 2
    ECC-4703
    Metabolic Dysfunction-Associated Steatohepatitis (MASH or… Eccogene (Shanghai) Co Ltd
  • Phase 3
    ECUR-506
    Ornithine-Transcarbamylase Deficiency iECURE Inc